Cost-Effectiveness Methods and Newborn Screening Assessment.

about

Cost-Effectiveness Methods and Newborn Screening Assessment.

Item

http://www.wikidata.org/entity/Q50041277

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cost-Effectiveness Methods and Newborn Screening Assessment.

@en

Cost-Effectiveness Methods and Newborn Screening Assessment.

@nl

type

Item

label

Cost-Effectiveness Methods and Newborn Screening Assessment.

@en

Cost-Effectiveness Methods and Newborn Screening Assessment.

@nl

prefLabel

Cost-Effectiveness Methods and Newborn Screening Assessment.

@en

Cost-Effectiveness Methods and Newborn Screening Assessment.

@nl

P1476

Cost-Effectiveness Methods and Newborn Screening Assessment

@en

P2093

C Valcárcel-Nazco

http://www.w3.org/2001/XMLSchema#string

I Castilla-Rodríguez

http://www.w3.org/2001/XMLSchema#string

J Mar

http://www.w3.org/2001/XMLSchema#string

L Vallejo-Torres

http://www.w3.org/2001/XMLSchema#string

P Serrano-Aguilar

http://www.w3.org/2001/XMLSchema#string

P2860

EuroQol--a new facility for the measurement of health-related quality of life

Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening

A review of health utilities across conditions common in paediatric and adult populations.

Diagnosis and management of glutaric aciduria type I--revised recommendations.

The impact of false-positive newborn screening results on families: a qualitative study.

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.

Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management.

Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years

P304

267-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/978-3-319-67144-4_16

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1031

http://www.w3.org/2001/XMLSchema#string

P50

María L Couce

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29214578

http://www.w3.org/2001/XMLSchema#string